Pharmaceuticals

Chronic Pain Treatment Sector Forecast Shows Robust Momentum, Climbing to $168.99 Billion With 9.1% CAGR

February 13, 2026February 13, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the chronic pain treatment market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Chronic Pain Treatment Market in 2030?

The chronic pain treatment market size has experienced significant expansion in recent years. Looking ahead, this market is projected to expand from $109.05 billion in 2025 to $119.32 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 9.4%. Factors such as opioid usage, musculoskeletal disorders, an aging population, the presence of hospital pain clinics, and advancements in post-surgical pain management are identified as contributors to its historical growth.

The chronic pain treatment market size is anticipated to experience substantial expansion in the coming years. It is projected to reach $168.99 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.1%. This growth throughout the forecast period can be ascribed to factors such as opioid regulation, device-based therapies, the prevalence of chronic diseases, integration of mental health services, and the expansion of outpatient pain care. Key trends expected during the forecast period encompass a movement towards non-opioid pain treatments, the rise of neuromodulation devices, broader multidisciplinary pain management, heightened emphasis on personalized pain care, and the incorporation of psychological support therapies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp

What Drivers Are Influencing Production Trends In The Chronic Pain Treatment Market?

The increasing occurrence of arthritis pain is anticipated to fuel the expansion of the chronic pain treatment market in the foreseeable future. Arthritis pain describes the discomfort, aching, or tenderness experienced in joints, resulting from inflammation or degeneration caused by arthritis. The increasing incidence of arthritis pain is mainly attributed to the growing elderly population, as the natural wear and tear of joints intensifies with age, contributing to a higher number of arthritis-related conditions. Chronic pain treatment aids in alleviating arthritis pain by addressing inflammation and nerve sensitivity, thereby reducing discomfort, improving joint mobility, and enhancing the overall well-being for those with ongoing arthritis symptoms. For example, in July 2024, data from the Centers for Disease Control and Prevention, a government agency based in the US, indicated that approximately 21.2% of adults aged 18 and older in the US had received an arthritis diagnosis in 2023. Consequently, the growing prevalence of arthritis pain is a significant factor propelling the growth of the chronic pain treatment market.

Which Segments Are Gaining Traction In The Chronic Pain Treatment Market?

The chronic pain treatment market covered in this report is segmented –

1) By Product Type: Drugs, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By Distribution channels: Direct, Indirect

4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications

2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

What Industry Trends Are Transforming The Chronic Pain Treatment Market?

Leading companies in the chronic pain treatment market are concentrating on developing advanced solutions, such such as closed-loop spinal cord stimulation (SCS) systems. This effort aims to address the growing demand for innovative non-opioid treatments, more effective long-term pain management, and an enhanced quality of life for patients. Unlike conventional open-loop SCS devices which provide fixed and unresponsive output, closed-loop SCS systems are implantable, rechargeable neurostimulators designed to continuously detect neural signals and dynamically modify electrical stimulation in real time. An example of this advancement is Medtronic plc, an Ireland-based medical device company, which secured U.S. Food and Drug Administration (FDA) approval in April 2024 for its Inceptiv Neurostimulation System. This system is a compact, rechargeable implant that employs sensing electrodes to observe evoked neural responses and automatically tailor stimulation. It offers full-body 1.5T and 3T MRI access with impedance-independent sensing and is specifically indicated for chronic, intractable trunk or limb pain. The design of the Inceptiv system targets more stable pain relief, superior patient outcomes, and greater comfort when contrasted with older fixed-output SCS systems.

Who Are The Major Companies Operating In The Chronic Pain Treatment Market?

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Chronic Pain Treatment Market?

North America was the largest region in the chronic pain treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Chronic Pain Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24504&type=smp

Browse Through More Reports Similar to the Global Chronic Pain Treatment Market 2026, By The Business Research Company

Chronic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Pain Management Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Cold Pain Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795